Cormorant Asset Management, LP Rapt Therapeutics, Inc. Transaction History
Cormorant Asset Management, LP
- $1.74 Billion
- Q1 2024
A detailed history of Cormorant Asset Management, LP transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Cormorant Asset Management, LP holds 496,750 shares of RAPT stock, worth $1.52 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
496,750
Previous 496,750
-0.0%
Holding current value
$1.52 Million
Previous $12.3 Million
63.87%
% of portfolio
0.26%
Previous 0.74%
Shares
3 transactions
Others Institutions Holding RAPT
# of Institutions
148Shares Held
29.2MCall Options Held
709KPut Options Held
1.06M-
Column Group LLC San Francisco, CA2.68MShares$8.18 Million15.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$7.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$7.54 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.03MShares$6.19 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.91MShares$5.81 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $90.5M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...